Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duanchen Sun

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Matrix Biology : Journal of the International Society for Matrix Biology|November 28, 2021
Mammary collagen is under reproductive control with implications for breast cancerQiuchen Guo, Duanchen Sun, Alexander S Barrett, et al.
Oncogene|April 19, 2019
BET bromodomain inhibition blocks the function of a critical AR-independent master regulator network in lethal prostate cancerDaniel J Coleman, Lina Gao, Carly J King, et al.
Neoplasia (New York, N.Y.)|May 14, 2020
Alternative splicing of LSD1+8a in neuroendocrine prostate cancer is mediated by SRRM4Daniel J Coleman, David A Sampson, Archana Sehrawat, et al.
Cancer Discovery|September 22, 2021
Mesenchymal Lineage Heterogeneity Underlies Nonredundant Functions of Pancreatic Cancer-Associated FibroblastsErin J Helms, Mark W Berry, R Crystal Chaw, et al.
Cell Stem Cell|December 24, 2025
3D post-implantation co-culture of human embryo and endometriumJinzhu Song, Rusong Zhao, Yu Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2020
Copy Number Loss of 17q22 Is Associated with Enzalutamide Resistance and Poor Prognosis in Metastatic Castration-Resistant Prostate CancerXiangnan Guan, Duanchen Sun, Eric Lu, et al.
European Urology|April 1, 2019
Genomic Drivers of Poor Prognosis and Enzalutamide Resistance in Metastatic Castration-resistant Prostate CancerWilliam S Chen, Rahul Aggarwal, Li Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 20, 2020
Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistanceJoshi J Alumkal, Duanchen Sun, Eric Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2021
BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity ProgramDae-Hwan Kim, Duanchen Sun, William K Storck, et al.
Nature Communications|September 15, 2022
Transcriptional profiling of matched patient biopsies clarifies molecular determinants of enzalutamide-induced lineage plasticityThomas C Westbrook, Xiangnan Guan, Eva Rodansky, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Matrix Biology : Journal of the International Society for Matrix Biology|November 28, 2021
Mammary collagen is under reproductive control with implications for breast cancerQiuchen Guo, Duanchen Sun, Alexander S Barrett, et al.
Oncogene|April 19, 2019
BET bromodomain inhibition blocks the function of a critical AR-independent master regulator network in lethal prostate cancerDaniel J Coleman, Lina Gao, Carly J King, et al.
Neoplasia (New York, N.Y.)|May 14, 2020
Alternative splicing of LSD1+8a in neuroendocrine prostate cancer is mediated by SRRM4Daniel J Coleman, David A Sampson, Archana Sehrawat, et al.
Cancer Discovery|September 22, 2021
Mesenchymal Lineage Heterogeneity Underlies Nonredundant Functions of Pancreatic Cancer-Associated FibroblastsErin J Helms, Mark W Berry, R Crystal Chaw, et al.
Cell Stem Cell|December 24, 2025
3D post-implantation co-culture of human embryo and endometriumJinzhu Song, Rusong Zhao, Yu Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2020
Copy Number Loss of 17q22 Is Associated with Enzalutamide Resistance and Poor Prognosis in Metastatic Castration-Resistant Prostate CancerXiangnan Guan, Duanchen Sun, Eric Lu, et al.
European Urology|April 1, 2019
Genomic Drivers of Poor Prognosis and Enzalutamide Resistance in Metastatic Castration-resistant Prostate CancerWilliam S Chen, Rahul Aggarwal, Li Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 20, 2020
Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistanceJoshi J Alumkal, Duanchen Sun, Eric Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2021
BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity ProgramDae-Hwan Kim, Duanchen Sun, William K Storck, et al.
Nature Communications|September 15, 2022
Transcriptional profiling of matched patient biopsies clarifies molecular determinants of enzalutamide-induced lineage plasticityThomas C Westbrook, Xiangnan Guan, Eva Rodansky, et al.
Pageof 3